info@seagull-health.com
SeagullHealth
语言:
search
new
How to Use Nitroxolin Capsules (Nitroxolinforte)
505
Article source: Seagull Pharmacy
Nov 24, 2025

Nitroxolin Capsules (Nitroxolinforte) is an antibacterial medication specifically indicated for the treatment of urinary tract infections, exerting significant inhibitory effects on susceptible bacteria and yeasts.

How to Use Nitroxolin Capsules (Nitroxolinforte)

Administration Route and Timing

This medication is administered orally. It is recommended to take it with an adequate amount of water (e.g., one glass) approximately 1 hour before meals.

For the prevention of recurrent infections, administration before bedtime in the evening is recommended.

Standard Dosage Regimen

Treatment of Acute Infections: Adults: 1 capsule once, 3 times daily.

Treatment of Chronic Infections and Prevention of Recurrence: 1–2 capsules daily.

Specific Prevention Regimen: 1–2 capsules once daily.

Administration Precautions

Maintain adequate fluid intake during treatment.

Excretion of the medication in urine may cause harmless yellow discoloration of urine, which may stain clothing but can be removed by normal washing.

It is recommended to avoid wearing synthetic fiber clothing during treatment.

Dosage Adjustments for Nitroxolin Capsules (Nitroxolinforte)

Patients with Renal Impairment

Mild renal impairment (serum creatinine ≤ 2 mg/100 mL): May be used as usual, but drug excretion may be delayed.

Severe renal impairment: Not recommended, as drug excretion and clinical efficacy cannot be guaranteed.

Regular monitoring of liver function indices is required during long-term treatment.

Management of Missed Dose and Overdose

Missed Dose: Continue taking the medication as scheduled; do not take a double dose to make up for the missed one.

Overdose: No special treatment is generally required for mild overdose; consult a physician in case of severe overdose.

Use in Special Populations

Children and Adolescents

Due to the inappropriate dosage strength, this product is not suitable for use in individuals under 18 years of age. Other formulations with low dosage strengths should be selected for this age group.

Patients with Hepatic or Renal Dysfunction

Severe hepatic or renal dysfunction: Contraindicated.

Mild hepatic impairment: Use with close monitoring.

Pregnancy and Lactation

Pregnancy: Use only if the benefit to the mother outweighs the potential risk to the fetus, as animal studies have shown possible effects on the fetal nervous system.

Lactation: Not recommended, as it may affect the infant’s intestinal flora, leading to diarrhea or yeast infections.

Elderly Patients

Special attention should be paid to renal function status and intravascular volume when using this medication in elderly patients; dosage adjustment may be necessary if indicated.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
What is Nitroxolin Capsules (Nitroxolinforte)?
Nitroxolin Capsules (Nitroxolinforte) is an antibacterial medication specifically indicated for the treatment of urinary tract infections. As a quinolone derivative, it possesses a unique dual mechani...
How to Purchase Nitroxolin Capsules (Nitroxolinforte)?
Nitroxolin Capsules (Nitroxolinforte) is a prescription medication for the treatment of urinary tract infections, manufactured by MIP Pharma GmbH for the German market.How to Purchase Nitroxolin Capsu...
What are the Side Effects of Canagliflozin Hydrochloride (Canaglu)?
Canagliflozin Hydrochloride (Canaglu) is a sodium-glucose cotransporter 2 (SGLT2) inhibitor that lowers blood glucose levels by inhibiting renal glucose reabsorption. Like all medications, canaglifloz...
How to Use Canagliflozin Hydrochloride (Canaglu)
Canagliflozin Hydrochloride (Canaglu) is a new-generation sodium-glucose cotransporter 2 (SGLT2) inhibitor that provides an innovative solution for type 2 diabetes mellitus management through a unique...
What Are the Purchase Channels for Vabysmo (Faricimab)?
Vabysmo (faricimab) is a dual inhibitor of vascular endothelial growth factor (VEGF) and angiopoietin-2 (Ang-2), widely used in the treatment of neovascular age-related macular degeneration (nAMD), di...
What Are the Indications for Vabysmo (Faricimab)?
Vabysmo (faricimab) is an innovative bispecific antibody drug that simultaneously targets vascular endothelial growth factor (VEGF) and angiopoietin-2 (Ang-2), providing a new option for the treatment...
What Are the Precautions for Using Vabysmo (Faricimab)?
Vabysmo (faricimab) is a dual-pathway inhibitor approved in recent years, demonstrating significant therapeutic effects by simultaneously targeting vascular endothelial growth factor (VEGF) and angiop...
Side Effects of Vabysmo (Faricimab)
Vabysmo (faricimab) is a bispecific antibody drug that has shown promising efficacy in improving visual outcomes, but it is accompanied by a series of side effects and precautions that require vigilan...
Related Articles
Dosage and Administration, Recommended Dose of Elacestrant (Orserdu)
Elacestrant (Orserdu) is a selective estrogen receptor degrader (SERD), which provides an important treatment option for patients with estrogen receptor-positive, HER2-negative advanced or metastatic ...
What Are the Indications for Elacestrant (Orserdu)?
Elacestrant (Orserdu) is a novel endocrine therapy agent that demonstrates significant value in the treatment of advanced breast cancer with specific gene mutations. As an estrogen receptor antagonist...
What Are the Purchase Channels for Elacestrant (Orserdu)?
With the advancement of medical technology, elacestrant (Orserdu), a targeted drug for breast cancer with specific gene mutations, has brought new treatment options for patients. As the first oral sel...
Adverse Reactions of Capmatinib (Tabrecta)
Capmatinib (Tabrecta) is a highly selective MET inhibitor indicated for the treatment of patients with advanced non-small cell lung cancer harboring MET gene mutations. By precisely inhibiting the act...
What are the Precautions for Capmatinib (Tabrecta) Administration?
Capmatinib (Tabrecta) is a targeted therapy drug for MET gene mutations, demonstrating significant efficacy in the treatment of advanced malignancies such as non-small cell lung cancer.What are the Pr...
Dosage and Administration, Recommended Dosage of Capmatinib (Tabrecta)
Capmatinib (Tabrecta) is a highly selective MET inhibitor, offering a precision treatment option for patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutation...
What Are the Indications for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a targeted therapy medication that plays an important role in the treatment of non-small cell lung cancer associated with specific gene mutations. As a MET kinase inhibitor, i...
What Are the Purchase Channels for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a highly selective MET inhibitor that has demonstrated significant efficacy in patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutat...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved